Inside Precision Medicine Experimental Add-On Drug Achieves “Striking” Results in Treatment-Resistant Schizophrenia

News & Features

Experimental Add-On Drug Achieves “Striking” Results in Treatment-Resistant Schizophrenia

January 3, 2023

Podcast Series

Behind the Breakthroughs

Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.

In Conversation with Vanessa Carter and Sue Charles

Multi-Omics: Unlocking the Complexity of the Proteome

5 Key AI Players Leading the Drug Discovery Push

Gene-Edited Pig Kidney Successfully Xenotransplanted in Living Patient at MGH

Stroke Medication Treatment Window Could Be Wider

Newron Pharmaceuticals SpA

Experimental Add-On Drug Achieves “Striking” Results in Treatment-Resistant Schizophrenia

Podcast Series

Behind the Breakthroughs

Related Content

Gene-Edited Pig Kidney Successfully Xenotransplanted in Living Patient at MGH

Stroke Medication Treatment Window Could Be Wider

Making More Cases of Pancreatic Cancer Treatable

Look Who’s Talking: Proteomic Biomarker Improves Preterm Birth Outcomes